Differences in coronary disease severity at time of acute coronary syndrome between Middle East and North America
Cardiovascular Diagnosis and Therapy · 2026-06 · 16 (3) · 54-54
DOI: 10.21037/cdt-2025-53 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Diagnosis and Therapy, 2026-06. Verfasst von Firas J Al Badarin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Heart & Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart & Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
- Lerner College of Medicine, Case-Western Reserve University, Cleveland, OH, USA.
- Heart & Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
- Academic Office, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Zitieren
APA
Al Badarin, F. J., Edris, A., Hashmani, S., Kaur, M., Shekhar, S., Kanwar, O., Kapadia, S., & Tuzcu, E. M. (2026). Differences in coronary disease severity at time of acute coronary syndrome between Middle East and North America. Cardiovascular Diagnosis and Therapy, 16(3), 54-54. https://doi.org/10.21037/cdt-2025-53
Vancouver
Al Badarin FJ, Edris A, Hashmani S, Kaur M, Shekhar S, Kanwar O, et al. Differences in coronary disease severity at time of acute coronary syndrome between Middle East and North America. Cardiovascular Diagnosis and Therapy. 2026;16(3):54-54. doi:10.21037/cdt-2025-53
BibTeX
@article{AlBadarin2026,
author = {Al Badarin, Firas J and Edris, Ahmad and Hashmani, Shahrukh and Kaur, Manpreet and Shekhar, Shashank and Kanwar, Oshin and Kapadia, Samir and Tuzcu, Emin Murat},
title = {Differences in coronary disease severity at time of acute coronary syndrome between Middle East and North America},
journal = {Cardiovascular Diagnosis and Therapy},
year = {2026},
volume = {16},
number = {3},
pages = {54--54},
doi = {10.21037/cdt-2025-53}
}
EUVIMED